APR 02, 2018 1:38 PM PDT

How does Johne's disease evade the immune system?

WRITTEN BY: Kara Marker

An infectious disease that afflicts cattle all over the world is particularly devastating because it can inhibit the animals’ immune systems. In a new study from Hokkaido University, the National Agriculture and Food Research Organization (NARO), and Tohoku University in Japan, researchers identify the molecular culprits responsible for this disease’s infectiousness.

Johne's Disease is a disease of cattle caused by a bacterium which is hard to detect until clinical signs appear. It causes losses due to emaciation and death. Credit: CSIRO

Johne’s disease is a contagious, chronic bovine disease that is usually fatal. Massive outbreaks of the disease in countries all over the world cause huge problems for cattle farmers. The disease is caused by Mycobacterium avium, which is related to the bacteria that cause leprosy and tuberculosis. Affected cows first show signs of weight loss and diarrhea with normal appetite; swelling under the jaw occurs several weeks after that, after which animals don’t live very long. Cows found to have the disease are killed before they can spread the disease to other animals. Vaccines and other preventative methods have not been successful.

In the new study, researchers chose to analyze a common metabolite of arachidonic acid, called prostaglandin E2 (PGE2), levels of which increase in cattle with Johne’s disease. PGE2 is controlled by cyclooxygenase (COX) enzymes, and it is involved in increasing vascular permeability, fever generation, and hyperalgesia (increased sensitivity to pain) during inflammation.

From their analysis of immune cells isolated from infected cows, researchers found that PGE2 impairs the immune response by upregulating expression of a molecule called programmed death-ligand 1 (PD-L1). This molecule can block activity of the immune system when it would normally launch an attack against the invading pathogen. Additionally, researchers discovered that PGE2 suppresses T cells, key players in the immune system during a pathogenic attack.

"Our data suggests that immunosuppressive effects of PGE2 are strongly connected to the progression of Johne's disease," explained Hokkaido University’s Satoru Konnai. "We plan to conduct clinical trials to verify how the COX-2 inhibitor and anti-PD-L1 antibodies boost immune responses in cattle with Johne's disease, in addition to examining the roles of PGE2 in cattle afflicted with other diseases."

Konnai and others are hoping that their findings will improve prevention techniques for Johne’s disease. For example, inhibiting cyclooxygenase-2 (COX-2) boosts the immune response to Johne’s disease, as COX-2 is vital for the production of PGE2. Researchers could also block PD-L1.

The present study was published in the journal Infection and Immunity.

Sources: USDA Animal and Plant Health Inspection Service, Immunology and Cell Biology, Hokkaido University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 05, 2020
Immunology
Intercepting Cancer Cells Before They Can Dodge the Immune System
AUG 05, 2020
Intercepting Cancer Cells Before They Can Dodge the Immune System
The battle that naturally occurs between the body’s immune system and cancerous cells is one that scientists have ...
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 03, 2020
Immunology
A Low-Cost COVID-19 Treatment, Made in Horses
SEP 03, 2020
A Low-Cost COVID-19 Treatment, Made in Horses
Researchers in Costa Rica are turning to horses as an unlikely source of potential therapeutic antibodies against COVID- ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
Loading Comments...